Professor of Otolaryngology-Head and Neck Surgery, Professor of Pathology, Professor of Urology, Professor of Oncology, Johns Hopkins University School of Medicine; Director, Head and Neck Cancer Research
Internal Medicine
Dr. David D. Sidransky, MD
|
|
Give Review
Doctor David D. Sidransky, MD practices Internal Medicine. He graduated from Baylor College of Medicine. He has 1 awards "Whos Who in Medicine and Healthcare". Doctor David D. Sidransky, MD has written publications. He has 37 publications published with PubMed. The lastest publication is: 'Designing a broad-spectrum integrative approach for cancer prevention and treatment.'
Publications
- Designing a broad-spectrum integrative approach for cancer prevention and treatment.
- Paired Box 5 Methylation Detection by Droplet Digital PCR for Ultra-Sensitive Deep Surgical Margins Analysis of Head and Neck Squamous Cell Carcinoma.
- A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma.
- Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use.
- Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.
- Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells.
- Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity.
- An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transu...
- Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.
- Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.
- GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.
- Clusterin Is a Gene-Specific Target of microRNA-21 in Head and Neck Squamous Cell Carcinoma.
- Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
- Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, ...
- PD-L1 expression in the Merkel cell carcinoma microenvironment: Association with inflammation, Merkel cell polyomavirus and overall survival.
- Cellular FLICE-like inhibitory protein long form (c-FLIPL) overexpression is related to cervical cancer progression.
- Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
- Clinical Correlates of Promoter Hypermethylation of Four Target Genes in Head and Neck Cancer: A Cooperative Group Correlative Study.
- Identification of guanine nucleotide-binding protein ?-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling.
- Hypermethylation of Genes Detected in Urine from Ghanaian Adults with Bladder Pathology Associated with Schistosoma haematobium Infection.
- Cigarette smoke induces methylation of the tumor suppressor gene NISCH.
- SH3GL2 is frequently deleted in non-small cell lung cancer and downregulates tumor growth by modulating EGFR signaling.
- Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.
- OGDHL Is a Modifier of AKT-Dependent Signaling and NF-κB Function.
- Suprabasin is hypomethylated and associated with metastasis in salivary adenoid cystic carcinoma.
- Tissue imprint for molecular mapping of deep surgical margins in patients with head and neck squamous cell carcinoma.
- Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.
- Dose-Dependent Activation of Putative Oncogene SBSN by BORIS.
- Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ 2 and RASSF1A in thyroid cancer.
- Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.
- Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes.
- Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
- MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma.
- Genome-wide and gene-specific epigenomic platforms for hepatocellular carcinoma biomarker development trials.
- Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression.
- The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase Inhibitors.
Schools
Baylor University
Baylor
Johns Hopkins University
Doctors Specialties
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
Johns Hopkins University -
Baylor College of Medicine
Hospital
-
Johns Hopkins Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Scott Wright, MD |
|
|
Dr. Susan H. Rubinstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen H. Glasser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Kishore Udyavar, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Selam Tewolde, MD |
|
|
Dr. Ronan J. Kelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nisha P. Soprey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William G. Nelson, MD |
|
|
Dr. Manuel H. Medina, MD |